Dow Up 0.23% Nasdaq Up 0.29%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
3.01 Down 0.01(0.33%) 11:04AM EDT - Nasdaq Real Time Price
Prev Close:3.02
Open:2.99
Bid:3.01 x 2900
Ask:3.02 x 5700
1y Target Est:12.50
Beta:1.42
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:2.92 - 3.04
52wk Range:2.62 - 7.22
Volume:314,247
Avg Vol (3m):1,395,030
Market Cap:314.15M
P/E (ttm):N/A
EPS (ttm):-1.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNTA

Comparison

Symbol% ChgMkt Cap
SNTADown 0.33%314.15M
INFIUp 1.59%652.51M
NVSUp 0.72%218.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.02
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback